APA Zitierstil

Loftus, B., Newsom, B., Montgomery, M., Von Gynz-Rekowski, K., Riser, M., Inman, S., . . . Williams, J. C. (2009). Autologous attenuated T-cell vaccine (Tovaxin) dose escalation in multiple sclerosis relapsing-remitting and secondary progressive patients nonresponsive to approved immunomodulatory therapies. Clinical immunology (Orlando, Fla.), 131(2), 202. https://doi.org/10.1016/j.clim.2009.01.005

Chicago Zitierstil

Loftus, B., et al. "Autologous Attenuated T-cell Vaccine (Tovaxin) Dose Escalation in Multiple Sclerosis Relapsing-remitting and Secondary Progressive Patients Nonresponsive to Approved Immunomodulatory Therapies." Clinical Immunology (Orlando, Fla.) 131, no. 2 (2009): 202. https://dx.doi.org/10.1016/j.clim.2009.01.005.

MLA Zitierstil

Loftus, B., et al. "Autologous Attenuated T-cell Vaccine (Tovaxin) Dose Escalation in Multiple Sclerosis Relapsing-remitting and Secondary Progressive Patients Nonresponsive to Approved Immunomodulatory Therapies." Clinical Immunology (Orlando, Fla.), vol. 131, no. 2, 2009, p. 202.